Literature DB >> 19260778

A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering.

Limin Wang1, Ivy Tran, Kiran Seshareddy, Mark L Weiss, Michael S Detamore.   

Abstract

Bone marrow-derived mesenchymal stem cells (BMSCs) have long been considered the criterion standard for stem cell sources in musculoskeletal tissue engineering. The true test of a stem cell source is a side-by-side comparison with BMSCs. Human umbilical cord-derived mesenchymal stromal cells (hUCMSCs), one such candidate with high potential, are a fetus-derived stem cell source collected from discarded tissue (Wharton's jelly) after birth. Compared with human BMSCs (hBMSCs), hUCMSCs have the advantages of abundant supply, painless collection, no donor site morbidity, and faster and longer self-renewal in vitro. In this 6-week study, a chondrogenic comparison was conducted of hBMSCs and hUCMSCs in a three-dimensional (3D) scaffold for the first time. Cells were seeded on polyglycolic acid (PGA) scaffolds at 25 M cells/mL and then cultured in identical conditions. Cell proliferation, biosynthesis, and chondrogenic differentiation were assessed at weeks 0, 3, and 6 after seeding. At weeks 3 and 6, hUCMSCs produced more glycosaminoglycans than hBMSCs. At week 6, the hUCMSC group had three times as much collagen as the hBMSC group. Immunohistochemistry revealed the presence of collagen types I and II and aggrecan in both groups, but type II collagen staining was more intense for hBMSCs than hUCMSCs. At week 6, the quantitative reverse transcriptase polymerase chain reaction (RT-PCR) revealed less type I collagen messenger RNA (mRNA) with both cell types, and more type II collagen mRNA with hBMSCs, than at week 3. Therefore, it was concluded that hUCMSCs may be a desirable option for use as a mesenchymal cell source for fibrocartilage tissue engineering, based on abundant type I collagen and aggrecan production of hUCMSCs in a 3D matrix, although further investigation of signals that best promote type II collagen production of hUCMSCs is warranted for hyaline cartilage engineering.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19260778     DOI: 10.1089/ten.tea.2008.0393

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  67 in total

1.  ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.

Authors:  Kalamegam Gauthaman; Chui-Yee Fong; Arjunan Subramanian; Arijit Biswas; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

2.  Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals.

Authors:  Nathan H Dormer; Milind Singh; Limin Wang; Cory J Berkland; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2010-04-09       Impact factor: 3.934

Review 3.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

4.  Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering.

Authors:  Limin Wang; Liang Zhao; Michael S Detamore
Journal:  J Tissue Eng Regen Med       Date:  2010-12-30       Impact factor: 3.963

5.  Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells.

Authors:  Limin Wang; Mark L Weiss; Michael S Detamore
Journal:  Recent Pat Regen Med       Date:  2013

6.  Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering.

Authors:  Qi Tan; Pauline Po Yee Lui; Yun Feng Rui; Yin Mei Wong
Journal:  Tissue Eng Part A       Date:  2011-12-13       Impact factor: 3.845

7.  Role of Cartilage Forming Cells in Regenerative Medicine for Cartilage Repair.

Authors:  Lin Sun; Michaela R Reagan; David L Kaplan
Journal:  Orthop Res Rev       Date:  2010-09-01

8.  Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation.

Authors:  Yi Shu; Chao Yang; Xiaojuan Ji; Linghuan Zhang; Yang Bi; Ke Yang; Mengjia Gong; Xing Liu; Qi Guo; Yuxi Su; Xiangyang Qu; Guoxin Nan; Chen Zhao; Zongyue Zeng; Xinyi Yu; Ruyi Zhang; Shujuan Yan; Jiayan Lei; Ke Wu; Ying Wu; Liping An; Shifeng Huang; Cheng Gong; Chengfu Yuan; Wei Liu; Bo Huang; Yixiao Feng; Bo Zhang; Zhengyu Dai; Yi Shen; Wenping Luo; Xi Wang; Rex C Haydon; Hue H Luu; Russell R Reid; Jennifer Moriatis Wolf; Michael J Lee; Tong-Chuan He; Yasha Li
Journal:  J Cell Biochem       Date:  2018-08-04       Impact factor: 4.429

9.  The bioactivity of agarose-PEGDA interpenetrating network hydrogels with covalently immobilized RGD peptides and physically entrapped aggrecan.

Authors:  Ganesh C Ingavle; Stevin H Gehrke; Michael S Detamore
Journal:  Biomaterials       Date:  2014-01-24       Impact factor: 12.479

10.  Isolation, characterization, and differentiation of stem cells for cartilage regeneration.

Authors:  Olivia S Beane; Eric M Darling
Journal:  Ann Biomed Eng       Date:  2012-08-21       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.